1. Home
  2. ATRC vs NGVT Comparison

ATRC vs NGVT Comparison

Compare ATRC & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • NGVT
  • Stock Information
  • Founded
  • ATRC 2000
  • NGVT 1964
  • Country
  • ATRC United States
  • NGVT United States
  • Employees
  • ATRC N/A
  • NGVT N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • NGVT Major Chemicals
  • Sector
  • ATRC Health Care
  • NGVT Industrials
  • Exchange
  • ATRC Nasdaq
  • NGVT Nasdaq
  • Market Cap
  • ATRC 1.6B
  • NGVT 1.6B
  • IPO Year
  • ATRC 2005
  • NGVT N/A
  • Fundamental
  • Price
  • ATRC $32.50
  • NGVT $44.59
  • Analyst Decision
  • ATRC Strong Buy
  • NGVT Buy
  • Analyst Count
  • ATRC 10
  • NGVT 3
  • Target Price
  • ATRC $49.60
  • NGVT $51.00
  • AVG Volume (30 Days)
  • ATRC 433.6K
  • NGVT 198.9K
  • Earning Date
  • ATRC 07-29-2025
  • NGVT 07-30-2025
  • Dividend Yield
  • ATRC N/A
  • NGVT N/A
  • EPS Growth
  • ATRC N/A
  • NGVT N/A
  • EPS
  • ATRC N/A
  • NGVT N/A
  • Revenue
  • ATRC $480,076,000.00
  • NGVT $1,350,300,000.00
  • Revenue This Year
  • ATRC $14.63
  • NGVT N/A
  • Revenue Next Year
  • ATRC $12.62
  • NGVT $4.95
  • P/E Ratio
  • ATRC N/A
  • NGVT N/A
  • Revenue Growth
  • ATRC 15.79
  • NGVT N/A
  • 52 Week Low
  • ATRC $20.20
  • NGVT $28.49
  • 52 Week High
  • ATRC $43.11
  • NGVT $51.67
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 48.10
  • NGVT 55.80
  • Support Level
  • ATRC $31.88
  • NGVT $41.04
  • Resistance Level
  • ATRC $33.00
  • NGVT $43.78
  • Average True Range (ATR)
  • ATRC 1.02
  • NGVT 1.17
  • MACD
  • ATRC -0.03
  • NGVT -0.06
  • Stochastic Oscillator
  • ATRC 41.45
  • NGVT 52.40

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: